Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia [1]

Journal of Clinical Psychopharmacology

Volumn 22, Issue 3, 2002, Pages 333-334

  Scheepers, Floortje E ^a   Gispen de Wied, Christine C ^a   Westenberg, Herman G M ^a   Kahn, René S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; GLUTAMIC ACID; OLANZAPINE;

ADULT; CENTRIFUGATION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LUMBAR PUNCTURE; MALE; NEGATIVE SYNDROME; NEUROTRANSMISSION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; GLUTAMIC ACID; HUMANS; MALE; PIRENZEPINE; SCHIZOPHRENIA;

EID: 0036113831     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200206000-00016     Document Type: Letter

References (20)

1. Recent advances in the phencyclidine model of schizophrenia
2. NMDA antagonists as neuroprotectants, psychotogens, neurotoxins and instructive research tools
3. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis
4. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
5. Effect of phencyclidine in chronic schizophrenics
6. Low cerebrospinal fluid glutamate in schizophrenic patients and new hypothesis of schizophrenia
7. Amino acid patterns in schizophrenia: Some new findings
8. Cerebrospinal fluid amino acid concentrations in chronic schizophrenia
9. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics
10. Enduring cognitive deficits and cortical dopamme dysfunction in monkeys after long-term administration of phencyclidine
11. Regulation of amino acid availability to brain: Selective control mechanisms for glutamate
12. Effects of haloperidol on CSF glutamate levels in drug-naive schizophrenic patients
13. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients
14. The comprehensive assessment of symptoms and history (CASH): An instrument for assessing diagnosis and psychopathology
15. The positive and negative syndrome scale (PANSS) for schizophrenia
16. Plasma amino acids determined by liquid chromatography within 17 minutes
17. Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia
18. The role of excitatory amino acids in neuropsychiatric illness
19. Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid
20. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism